{{one source|date=September 2014}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464377675
| IUPAC_name = 4-[(7-Chloro-2-methoxy-pyrido[3,2-b]quinolin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol
| image = Pyronaridine.svg

<!--Clinical data-->
| synonyms = Pyronaridine tetraphosphate
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  CLP (EU): Acute Tox. 3(H301), Eye Dam. 1 (H318), Repr. 2 (H361), Aquatic Chronic 4 (H413){{what|date=February 2017}}
| routes_of_administration = Oral, [[intramuscular injection]], [[intravenous therapy]]

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 74847-35-1
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 5485198
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 10647812
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = TD3P7Q3SG6
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 35228

<!--Chemical data-->
| C=29 | H=32 | Cl=1 | N=5 | O=2 
| molecular_weight = 518.05 g/mol
| smiles = Clc1ccc6c(c1)nc2ccc(OC)nc2c6Nc5cc(CN3CCCC3)c(O)c(CN4CCCC4)c5
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C29H32ClN5O2/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35/h6-9,14-16,36H,2-5,10-13,17-18H2,1H3,(H,31,32)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DJUFPMUQJKWIJB-UHFFFAOYSA-N
}}

'''Pyronaridine''' is an [[antimalarial drug]]. It was first made in 1970 and has been in clinical use in China since the 1980s.<ref>{{cite journal |vauthors=Chang C, Lin-Hua T, Jantanavivat C |title=Studies on a new antimalarial compound: pyronaridine |journal=Trans R Soc Trop Med Hyg |volume=86 |issue=1 |pages=7â€“10 |year=1992 |pmid=1566313 |doi=10.1016/0035-9203(92)90414-8}}</ref>

It is one of the components of the [[artemisinin combination therapy]] [[pyronaridine/artesunate]].

== References ==
{{Reflist}}

[[Category:Antimalarial agents]]
[[Category:Chinese discoveries]]


{{antiinfective-drug-stub}}